title: [Urotractin in the treatment of an infection of the kidneys, urinary tract and prostate].
abstract: Clinical and bacteriological effects of urotractin are analysed for 60 patients with infectious-inflammatory diseases of the kidney, urinary tracts and prostate treated in 3 urological clinics of Moscow. The drug was given 10 days in a dose 400 mg twice a day. Urotractin demonstrated high efficacy against both gram-negative and gram-positive bacteria. The results were the same in in- and outpatients.
authors.forename: N A
authors.initials: NA
authors.lastname: Lopatkin
authors.forename: M F
authors.initials: MF
authors.lastname: Trapeznikova
authors.forename: E B
authors.initials: EB
authors.lastname: Mazo
authors.forename: I I
authors.initials: II
authors.lastname: Derevianko
authors.forename: A B
authors.initials: AB
authors.lastname: Sobolevskiĭ
authors.forename: A N
authors.initials: AN
authors.lastname: Dolzhenok
authors.forename: V V
authors.initials: VV
authors.lastname: Meshkov
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage*; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009393:Nephritis / Q000188:drug therapy*; D010876:Pipemidic Acid / Q000008:administration & dosage*; D011472:Prostatitis / Q000188:drug therapy*; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy*
chemical_list: D000892:Anti-Infective Agents, Urinary; D010876:Pipemidic Acid